Frank R. Witney Witney

Frank R. Witney Witney

Directeur/Membre du Conseil chez STANDARD BIOTOOLS INC.

Fortune : 3 M $ au 31/05/2026

72 ans
Health Technology
Commercial Services
Electronic Technology

Profil

Franklin R.
Witney
is currently Lead Independent Director at Cerus Corp.
since 2025.
Independent Director at Revvity, Inc. since 2016.
Independent Director at Standard BioTools, Inc. since 2022.
Director at One Lambda, Inc., Revvity BV, and Leinco Technologies, Inc. Operating Partner at Ampersand Management LLC since 2016.
Formerly President, Chief Executive Officer & Director at Dionex Corp.
from 2009 to 2011.
President, Chief Executive Officer & Director at Affymetrix, Inc. from 2011 to 2016.
President & Chief Executive Officer at Panomics LLC from 2002 to 2008.
President & Chief Executive Officer at GenoSpectra, Inc. Chief Executive Officer & Director at eBioscience, Inc. Chairman at Exagen, Inc., Gyros AB, Gyros Protein Technologies AB, Canopy Biosciences LLC.
Independent Chairman at Jumpcode Genomics, Inc. Director at Transgenomic, Inc. from 2007 to 2009.
Director at DVS Sciences, Inc., GenapSys, Inc., Applied Precision LLC, Genoptix, Inc., Nexcelom Bioscience LLC, RareCyte, Inc., Alamar Biosciences, Inc., Emulate, Inc., BioEcho Life Sciences GmbH, Biologos LLC.
Independent Director at Telesis Bio, Inc. from 2020 to 2024.
Operations Manager-Life Science Group at Bio-Rad Laboratories, Inc. in 2000.
Chief Commercial Officer & Executive VP at Affymetrix, Inc. from 2008 to 2009.
President & Chief Operating Officer at Packard BioScience Co. from 2000 to 2001.
President-Drug Discovery Tools at PerkinElmer Life Sciences, Inc. from 2001 to 2002.
President at Drug Discovery Facility from 2001 to 2002.
Education includes a doctorate from Indiana University and undergraduate degree from the University of Illinois.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/05/2026 23 354 ( 0,02 % ) 2 M $ 31/05/2026
02/06/2026 220 059 ( 0,11 % ) 668 979 $ 31/05/2026
15/04/2026 120 495 ( 0,03 % ) 138 569 $ 31/05/2026
-.--%
20/04/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Frank R. Witney Witney

SociétésPosteDébut
CERUS CORPORATION Directeur/Membre du Conseil 24/03/2014
STANDARD BIOTOOLS INC. Directeur/Membre du Conseil 01/04/2022
REVVITY, INC. Directeur/Membre du Conseil 27/07/2016
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Private Equity Investor 01/01/2016
Directeur/Membre du Conseil 15/10/2009

Anciens postes connus de Frank R. Witney Witney

SociétésPosteFin
TELESIS BIO, INC. Président 27/08/2024
AFFYMETRIX, INC. Directeur Général 31/03/2016
░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Frank R. Witney Witney

Formation de Frank R. Witney Witney

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

60

Relations au 1er degré

35

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Electronic Technology

Health Services

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Frank R. Witney Witney
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇